Clarus Therapeutics Holdings, Inc. Warrants
CRXTW
CRXTW was delisted on the 30th of August, 2022.
22 hedge funds and large institutions have $3.75M invested in Clarus Therapeutics Holdings, Inc. Warrants in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, 4 reducing their positions, and 2 closing their positions.
500% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 2
83% more funds holding
Funds holding: 12 → 22 (+10)
20% more capital invested
Capital invested by funds: $3.12M → $3.75M (+$623K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
+$154K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$63.2K |
| 3 |
Walleye Capital
New York
|
+$28.2K |
| 4 |
HF
HRT Financial
New York
|
+$20.2K |
| 5 |
Walleye Trading
New York
|
+$18.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$127K |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$53.1K |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$17K |
| 4 |
BI
Bulldog Investors
Saddle Brook,
New Jersey
|
-$14.8K |
| 5 |
CCA
Cruiser Capital Advisors
Stamford,
Connecticut
|
-$11K |
CRXTW Hedge Fund Activity: Q2 2021 in Review
22 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Clarus Therapeutics Holdings, Inc. Warrants (CRXTW) for Q2 2021, worth a combined $3.75M — up 20% from $3.12M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new CRXTW positions and 2 closed out — a net gain of 10 holders — while 0 added to existing stakes and 4 trimmed.
The largest buyer was Yakira Capital Management, opening a new position worth an estimated $154K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $127K sold.
- 22 institutional investors held Clarus Therapeutics Holdings, Inc. Warrants (CRXTW) as of Q2 2021, up from 12 in Q1 2021.
- Funds reported $3.75M of Clarus Therapeutics Holdings, Inc. Warrants stock for Q2 2021, up 20% quarter-over-quarter.
- 12 funds opened new Clarus Therapeutics Holdings, Inc. Warrants positions in Q2 2021 and 2 closed out, a net change of +10 holders.
- The largest Clarus Therapeutics Holdings, Inc. Warrants buyer in Q2 2021 was Yakira Capital Management, an estimated $154K added.
- The largest Clarus Therapeutics Holdings, Inc. Warrants seller in Q2 2021 was Hudson Bay Capital Management, an estimated $127K sold.
Based on aggregated 13F filings for Q2 2021.